KELLY LAWRENCE W & ASSOCIATES INC/CA
Position in GILD — Gilead Sciences, Inc.
CIK 920441
PASADENA, CA
Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$763,598
-$78,754 QoQ
Shares Held
6,044
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#1,193
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 72%
Shared 0%
None 28%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KELLY LAWRENCE W & ASSOCIATES INC/CA holds $15,835,572 across 7 Drug Manufacturers - General names. GILD ranks #3 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
47,610 | $12,091,511 | |
| 2 | ABBV |
AbbVie Inc.
|
7,791 | $1,960,527 | |
| 3 | GILD |
Gilead Sciences, Inc.
This page
|
6,044 | $763,598 | |
| 4 | AMGN |
Amgen Inc
|
1,398 | $506,243 | |
| 5 | LLY |
ELI LILLY & Co
|
227 | $272,270 | |
| 6 | PFE |
Pfizer Inc
|
9,130 | $219,850 | |
| 7 | NVO |
Novo Nordisk A S
|
450 | $21,573 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $763,598 | 6,044 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $842,352 | 6,044 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $772,525 | 6,294 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $698,634 | 6,294 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $697,815 | 6,294 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $904,131 | 8,069 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $800,755 | 8,669 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $788,515 | 9,405 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $706,683 | 10,300 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $761,653 | 10,398 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $893,621 | 11,031 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $826,663 | 11,031 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $857,866 | 11,131 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $989,915 | 11,931 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $848,283 | 9,881 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $609,558 | 9,881 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $712,669 | 11,530 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $768,688 | 12,930 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,104,035 | 15,205 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,110,964 | 15,905 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,127,926 | 16,380 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,078,028 | 16,680 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $342,277 | 5,875 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,355,741 | 21,455 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,650,747 | 21,455 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,603,975 | 21,455 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||